Prior hypomethylating agent use lacks impact on clinical outcome in patients with secondary acute myeloid leukemia arising from myelodysplastic syndromes treated with standard induction chemotherapy
Crossref DOI link: https://doi.org/10.1007/s12185-016-1935-0
Published Online: 2016-01-18
Published Print: 2016-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Subari, Salih
Baidoun, Firas
Hreh, Muhanad
Patnaik, Mrinal
Hashmi, Shahrukh
Elliott, Michelle
Hogan, William
Litzow, Mark
Al-Kali, Aref
Text and Data Mining valid from 2016-01-18